関連する実験動画
Updated: Feb 18, 2026

11:14
Designing Silk-silk Protein Alloy Materials for Biomedical Applications
Published on: August 13, 2014
18.9K
免疫調節のための高ペイロードのシルク/バチラート材料の設計
Logan D Morton1, Julian B Gilbert2, Daniel V Percac2
1Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.
ACS macro letters
|February 17, 2026
まとめ
シルク繊維素 (SF) キャリアは,ブチラートのような短鎖脂肪酸 (SCFA) を効果的に提供します. 投与量だけでなく,ナノ粒子の投与は,炎症性マクロファージを再プログラムし,治療的免疫調節を達成するために重要です.
科学分野:
- バイオマテリアル科学 バイオマテリアル科学
- 免疫学 免疫学とは
- 薬物の配送システムです.
背景:
- ブチラートなどの短鎖脂肪酸 (SCFA) は強力な免疫調節剤です.
- SCFAの治療的応用は,生物学的利用可能性の低下,揮発性,および急速な代謝によって妨げられています.
- 従来のポリマー配送システムは,持続的で生物学的に関連するSCFA暴露を提供できることがよくありません.
研究 の 目的:
- 揮発性代謝産物の多用途のキャリアとしてシルク繊維素 (SF) を導入する.
- SCFA用の調節可能な負荷と放出プロファイルを持つSFベースの配送システムを開発する.
- 配送されたSCFAの免疫調節効果に対する物質形態の影響を調査する.
主な方法:
- ブチラートで満たされたシルク繊維ナノ粒子と多孔スポンジの製造.
- SCFAの負荷プロフィールと複数日間の放出プロフィールの特徴.
- マクロファージの再プログラムとサイトカイン生成のインビトロ評価 (IL-10)
主要な成果:
- SFキャリアによって,ビュチラートの持続的,フィキアン的な放出が,何日にもわたって可能になった.
- ナノ粒子媒介による投与は,炎症性マクロファージの再プログラムに不可欠でした.
- SFナノ粒子は,スポンジ形式とは異なり,抗炎症性IL-10の生産とM1からM2のマクロファージの極化を引き起こした.
結論:
- 物質形態学,特にナノ粒子の形状因子は,放出率に関係なく,SCFAの免疫調節効果に不可欠です.
- シルク繊維は,揮発性で迅速に代謝する内生代謝産物の提供のための有望なプラットフォームです.
- この研究は,SFベースの配信システムを用いて,免疫調節と代謝医学における新しい治療戦略を可能にします.
関連する概念動画
Site-Targeted Drug Delivery Systems: Polymeric Carriers
27
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
27
Development of Immunocompetence
1.0K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Immunological Memory
17.1K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.1K

